Cargando…
Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy
The pace of innovation is accelerating, and so medicines regulators need to actively innovate regulatory science to protect human and animal health. This requires consideration and consultation across all stakeholder groups. To this end, the European Medicines Agency worked with stakeholders to draf...
Autores principales: | Hines, Philip A., Gonzalez-Quevedo, Rosa, Lambert, Apolline I. O. M., Janssens, Rosanne, Freischem, Barbara, Torren Edo, Jordi, Claassen, Ivo J. T. M., Humphreys, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540226/ https://www.ncbi.nlm.nih.gov/pubmed/33072771 http://dx.doi.org/10.3389/fmed.2020.00508 |
Ejemplares similares
-
Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators
por: Saesen, Robbe, et al.
Publicado: (2023) -
Stakeholders’ Understanding of European Medicine Agency’s COVID-19 Vaccine Information Materials in EU and Regional Contexts
por: Castro, Indiana, et al.
Publicado: (2023) -
Goals in Nutrition Science 2020-2025
por: Bassaganya-Riera, Josep, et al.
Publicado: (2021) -
SIRT in 2025
por: Ponziani, Francesca Romana, et al.
Publicado: (2022) -
BR-247: Cosmic vision: space science for Europe 2015-2025
por: Bignami, Giovanni Fabrizio, et al.
Publicado: (2005)